Cytokinetics reported $4.07B in Market Capitalization this January of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US USD 2.65B 373M
Acorda Therapeutics ACOR:US USD 7M 1000K
Amgen AMGN:US USD 120.36B 9.61B
Bayer BAYN:GR EUR 46.58B 9.14B
Biogen BIIB:US USD 39.1B 9.24B
Brainstorm Cell Therapeutics BCLI:US USD 161M 60M
Bristol Myers Squibb BMY:US USD 151.8B 12.14B
Capricor Therapeutics CAPR:US USD 148M 63M
Cytokinetics CYTK:US USD 4.56B 1.2B
Eisai 4523:JP JPY 2.3T 600.25B
Eli Lilly And LLY:US USD 307.24B 831M
Exelixis EXEL:US USD 5.05B 1.63B
Geron GERN:US USD 884M 299M
Halozyme Therapeutics HALO:US USD 5.45B 622M
Intra Cellular Therapies ITCI:US USD 4.41B 977M
Ligand Pharmaceuticals LGND:US USD 1.45B 50M
Merk MRK:US USD 218.17B 12.39B
Novartis NOVN:VX USD 181.55B 12.79B
Pfizer PFE:US USD 245.6B 48.58B
Regeneron Pharmaceuticals REGN:US USD 75.09B 10.16B
Roche Holding ROG:VX CHF 263.11B 68.64B
Sanofi SAN:FP EUR 99.37B 22.52B